Zenodo (CERN European Organization for Nuclear Research)
August 17, 2026
Christopher P. Albertyn, Ron Shore, Linda E. Carlson et al.
As interest in psychedelic-assisted therapy grows, an important policy question remains largely unaddressed: who is responsible for ensuring safe, equitable, and accountable implementation within cancer care systems? This poster explores the emerging governance landscape for psychedelic-assisted therapy in Canada. Abstract Background: Psilocybin-assisted therapy (PAT) is emerging as a promising...
Current oncology (Toronto, Ont.)
December 22, 2025
Linda E. Carlson, Harriet Richardson, Ron Shore et al.
1 citation
The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) was launched in 2025 to address urgent gaps in supportive care for Canadians with cancer experiencing demoralization syndrome (loss of meaning, dysphoria, disheartenment, helplessness, a sense of failure) and related psychosocial distress. CAN-PACT has six major objectives: (1) to develop a national interdisciplinary...
Journal of Psychedelic Studies
September 11, 2025
Ron Shore, K. Dobson, Nina Thomson et al.
Abstract Background and Aims Psilocybin is a psychedelic compound that may hold promise for a wide range of human health conditions, yet the identification of therapeutic processes and mechanisms of action remains exploratory. We conducted a scoping review of pre-clinical behavioural investigations of psilocybin in non-human animals to identify behavioural effects, studies completed,...
European journal of anaesthesiology
May 1, 2025
Mansi Dave, Ron Shore, Tracy Cupido et al.
Psychedelic drugs, known for their perception-altering properties, are gaining popularity in the treatment of mental health and pain disorders. As exploratory studies demonstrate clinical efficacy with few adverse events, it is expected that more patients will ingest psychedelic drugs. For therapeutic reasons, as with any drug, anaesthesiologists must be aware of its physiological effects and...
bioRxiv (Cold Spring Harbor Laboratory)
January 5, 2024
Ron Shore, K. Dobson, Nina Thomson et al.
3 citations
preprint
Abstract Background and Aims Psilocybin is a psychedelic drug that may hold promise for a wide range of human health conditions, yet the identification of therapeutic processes and mechanisms of action remains exploratory. We conducted a scoping review on pre-clinical behavioural investigations of psilocybin in non-human animals to help determine the behavioural effects of psilocybin in...
medRxiv
December 12, 2019
Ron Shore, Paul Ioudovski, Craig Goldie et al.
8 citations
preprint
Abstract We conducted a scoping review on psilocybin-assisted therapy for addiction, depression, anxiety and post-traumatic stress disorder. Psilocybin is a naturally-occurring tryptophan derivative found in species of mushroom with psycho-active properties. From 2022 records identified by database searching, 40 publications were included in the qualitative synthesis from which we identified 9...